Envoy Medical, Inc.
COCH- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001840877
No open-market purchases or sales by Envoy Medical, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.9M in total; no superinvestor holds it.
Other share classesCOCHW
13F holders, Q3 2024
Institutional positions in Envoy Medical, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −1 vs. Q2 2024
- Shares held
- 1.03M
- −118.8K (−10.3%) vs. Q2 2024
- Total value
- $3.33M
- +$611.8K (+22.5%) vs. Q2 2024
- New holders
- 4
- 4 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.9M |
| Q1 2026 | 33 | $11.5M |
| Q4 2025 | 27 | $983.0K |
| Q3 2025 | 28 | $1.65M |
| Q2 2025 | 22 | $3.28M |
| Q1 2025 | 22 | $3.00M |
| Q4 2024 | 24 | $2.95M |
| Q3 2024 | 18 | $3.33M |
| Q2 2024 | 20 | $2.74M |
| Q1 2024 | 17 | $4.59M |
| Q4 2023 | 9 | $3.01M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Envoy Medical, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 21 | $68 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 74 | $240 | 0.00% | +17+29.8% | Added |
| Tower Research Capital LLC (TRC) | 1,312 | $4.26K | 0.00% | −2,729−67.5% | Reduced |
| Wells Fargo & Company | 1,938 | $6.30K | 0.00% | −806−29.4% | Reduced |
| American Capital Advisory, LLC | 2,000 | $6.50K | 0.00% | +2,000 | New |
| Safe Harbor Fiduciary, LLC | 2,500 | $8.13K | 0.01% | +2,500 | New |
| Advisor Group Holdings, Inc. | 10,000 | $32.5K | 0.00% | +7,000+233.3% | Added |
| WealthTrust Asset Management, LLC | 11,316 | $36.8K | 0.03% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 11,718 | $38.1K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 14,043 | $45.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,759 | $51.2K | 0.00% | +15,759 | New |
| State Street Corp | 23,872 | $77.6K | 0.00% | 00.0% | Unchanged |
| HighPoint Advisor Group LLC | 38,662 | $98.6K | 0.01% | +38,662 | New |
| Morgan Stanley | 31,541 | $102.5K | 0.00% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 38,162 | $124.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 88,544 | $287.9K | 0.00% | +1,585+1.8% | Added |
| Vanguard Group Inc | 185,961 | $604.4K | 0.00% | +70,033+60.4% | Added |
| Atlas Merchant Capital LLC | 555,527 | $1.81M | 2.43% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −164,322−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,042−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,698−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −726−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |